Articles tagged with Bone Marrow Cells
Researchers found that treating patients with their own bone marrow stem cells after a heart attack increased circulation within the heart. The study showed that higher doses of cells led to greater improvement in blood flow, but results for cardiac function were not significant.
Researchers at USC have identified a key mechanism that guides the migration of blood-forming stem cells to the bone marrow. The finding may lead to improved efficiency in bone marrow transplants by activating a specific signaling pathway.
Researchers have found that bone marrow cells can promote the regrowth of both blood vessels and the protective lining of nerves in diabetic animals. This discovery has potential implications for treating neuropathy in people with diabetes.
A study by Wajahat Mehal and colleagues found that aspirin reduces liver damage caused by acetaminophen overdose. In contrast, glucocorticoid therapy may cause varying levels of brain injury in neonates, depending on the type of steroid used. These findings have important implications for treatment strategies.
Researchers at Massachusetts General Hospital found a subpopulation of hematopoietic stem cells that reproduce much more slowly than expected. This discovery may lead to improved treatment outcomes for leukemia and other marrow-based diseases through enhanced bone marrow repopulation.
Researchers have found that bone marrow-derived stem cells can increase production of the col7 protein and form anchoring fibrils, improving the connection between the dermis and epidermis. This treatment has shown promise in increasing survival time and reducing blister formation in mouse models of the disease.
Researchers found that combining adult cardiomyocytes with bone marrow cells enhances therapeutic effects and reduces programmed cell death. The technique shows promise as a new strategy for myocardial repair, with potential applications in cardiac tissue regeneration.
The REGENT trial found that intracoronary infusion of CD34+CXCR4+ stem cells improved LVEF in patients with severely depressed baseline LVEF. While the treatment showed no significant improvement in overall patient groups, it was safe and feasible.
Recent studies in Biology of Reproduction suggest that maternal follicular testosterone influences the sex of bovine embryos, while research on maternal cell microchimerism reveals its presence in major organs of healthy newborn mice. These findings highlight the importance of understanding the mechanisms behind these phenomena.
Researchers have found that adult multipotent stem cells (MAPCs) are more effective than mononucleate cells in treating peripheral vascular disease, improving blood vessel regeneration and muscle function. The study used mouse models and human cells, with identical results, suggesting a potential new treatment option.
Researchers at MGH confirm that bone marrow transplantation after chemotherapy restores fertility in female mice, with donor-derived egg cells observed but not involved in fertilization. The study also reveals that resuming mating and bone marrow transplants shortly after chemotherapy improve fertility rates.
Aging hematopoietic stem cells decline in function due to increased inflammatory response and decreased chromatin remodeling, leading to epigenetic dysregulation. Despite this decline, overall blood production remains stable.
Researchers found that bone marrow stem cells can take on the appearance of malignant cells but do not have the same cellular behavior, casting doubt on the theory that they seed cancer. This discovery has implications for cancer treatment and study methods.
Researchers discovered that a new drug called AMD3100 can rapidly mobilize blood vessel-forming cells to reach injured areas, accelerating healing. This breakthrough has the potential to improve treatment outcomes for heart attacks and strokes.
Researchers at the University of Toronto have discovered bone marrow adult stem cells play a crucial role in repairing damaged hearts. The 'SOS' distress signal mobilizes these cells to stimulate new blood vessel growth and restore heart function.
Researchers at the University of Florida have found that bone marrow cells can regenerate damaged retinal pigment epithelium (RPE) cells, which play a crucial role in vision health. This breakthrough may lead to new treatments for diseases such as age-related macular degeneration and provide hope for patients with sight-robbing injuries.
Scientists at OHSU School of Medicine found that bone marrow-derived cells fuse with intestinal stem cells in both normal and diseased tissue, promoting tumor growth and cancer development. This discovery has implications for understanding the balance between rapid regeneration and cancer risk.
Researchers at Yale University have made a groundbreaking discovery that bone marrow cells can transform into functional gut lining cells after transplantation. This breakthrough has significant implications for the treatment of cystic fibrosis, an inherited disease characterized by mucus buildup in organs.
Researchers have made a breakthrough in cardiac regeneration using bone marrow stem cells, improving left ventricular function and reducing infarct size in patients with old myocardial infarction. The therapy is safe, simple, and shows promising results, paving the way for larger trials to confirm its effectiveness.
Researchers have discovered that malfunctioning bone marrow cells can cause premature cell death and dysfunction in nerve cells, leading to neuropathy. The study provides a basis for understanding the dangerous nerve condition in diabetics and may eventually lead to a treatment.
Researchers identify a new marker, CD150, that helps distinguish hematopoietic stem cells from progenitor cells. The discovery uses the SLAM family of genes to precisely identify stem cells in tissue sections.
Researchers discover CML's unique cell death protein, lipocalin 24p3, that destroys healthy bone marrow cells, allowing leukemia to grow and spread. Blocking this protein with an antibody may prove useful in treating CML patients when combined with traditional treatment.
Researchers at Indiana University have successfully transformed adult bone marrow stem cells into auditory neurons, offering new hope for treating deaf patients. The breakthrough involves the use of Sonic hedgehog and retinoic acid molecules to stimulate the growth of nerve cells in patients with profound hearing loss.
Researchers found that transplanted bone marrow cells reduced liver fibrosis in mice treated with carbon tetrachloride. The treatment also improved survival rates and increased serum albumin levels, suggesting a new concept for treating liver fibrosis.
Researchers found that bone marrow-derived cells cluster within the healing area of a wound, producing collagen type III, a key component of skin. This discovery suggests new ways to treat serious wounds, as these cells also maintain the matrix environment and integrity of the skin.
A blood stem cell has been found to give rise to bone in mice, suggesting a potential basis for treatments to repair or restore bone. The study used retroviral integration site analysis to prove that a single type of stem cell can produce two distinct bodily tissues.
Researchers discovered that donor-derived bone marrow cells can differentiate into human endometrial tissue, contributing to endometrial regeneration. This finding may lead to new treatments for uterine disorders like infertility, abnormal bleeding, and cancer.
Researchers found that bone marrow cells can differentiate into epithelial cells under normal circumstances, suggesting a new mechanism of transformation. However, the exact mechanisms behind this process are still unclear and require further investigation.
Researchers successfully induced neuronal cells from bone marrow stromal cells, offering a potential treatment option for neurological disorders. The findings have significant implications for the development of regenerative medicine techniques.
Researchers have discovered a way to convert adult bone marrow cells into brain stem cells, which could potentially restore functioning in individuals with Alzheimer's disease. The process eliminates ethical and logistical issues associated with fetal tissue use and allows for quick conversion within a few weeks.
Researchers found that ES cell lines can restore blood cells, including immune systems, in mice without being rejected. This breakthrough has potential advantages over traditional bone marrow or blood donations, offering a renewable source with low risk of graft-versus-host disease.
Researchers have discovered insulin-producing cells in various tissues in diabetic mice, which can be triggered by high blood sugar. The findings suggest that these cells could be harnessed to generate insulin-producing cells from other tissues, offering a potential breakthrough for diabetes treatment.
Human bone marrow-derived single stem cell lines can proliferate and differentiate into islet-like cells capable of glucose-related insulin production. Researchers implanted these cells into mice with type 1 diabetes, observing an apparent reduction in glucose levels after two weeks.
Researchers found that human bone marrow-derived multipotent stem cells can differentiate into both vessels and heart muscle, regenerating essential tissues of the heart. The study shows promise for treating acute and chronic heart failure and other blood vessel diseases.
A UCSF-led study found no evidence of trans-differentiation when bone marrow-derived cells fused with damaged tissue in mice, casting doubt on their potential as a treatment for brain and heart diseases. The researchers suggest that cell fusion might be a physiological mechanism for repairing damaged cells, but more research is needed.
Scientists at Duke University Medical Center discovered that age-related stem cell loss prevents artery repair and leads to atherosclerosis. The researchers found that bone marrow-derived vascular progenitor cells play a critical role in determining the onset and progression of atherosclerosis.
Researchers found that progenitor cells from the bone marrow contribute to atherosclerosis by seeding into plaque formations, and that these cells can also help stabilize vulnerable plaques. The study opens up new possibilities for preventing heart attacks.
Researchers at Johns Hopkins Medicine have found a new method for growing human embryonic stem cells using human marrow stromal cells, eliminating the need for mouse cells as feeders. This breakthrough could potentially lead to significant advancements in treating conditions like Parkinson's disease and diabetes.
Researchers have identified bone marrow stem cells with the ability to produce functional insulin-producing cells, offering a new potential avenue for treating diabetes. The study used a molecular biology technique called CRE-loxP to isolate and study these cells, which were found to exhibit characteristics of pancreatic beta cells.
Researchers have found that bone marrow cells from transplants can relocate to brain tissue, carrying Y chromosomes into Purkinje cells involved in balance and movement. This discovery suggests that these cells may act as a repair squad to treat damaged tissues throughout the body.
Researchers have found that bone marrow cells can enter the human brain and form new neurons, a phenomenon previously observed in mice. The study, led by Dr. Mezey, examined brain tissue from patients who received bone marrow transplants to treat leukemia and other diseases.
A team of scientists has developed a laboratory system to study the virus in its latent stage, discovering genes that may give it stealth capabilities. This could lead to the development of new drugs to clear the virus from infected individuals.
Researchers found that bone marrow cell transplantation significantly increased new capillary formation and improved blood flow in patients with PAD. The study's findings suggest that this therapy may help alleviate symptoms of PAD, including pain, fatigue, and ischemic ulcers, by promoting angiogenesis.
Researchers successfully treated patients with scar tissue and impaired heart function after heart attacks by injecting their own bone marrow into the affected area. The treatment showed significant improvement in heart wall motion, persisting for at least 10 months in some patients.
Researchers have developed a potential treatment for limb ischemia by injecting bone marrow cells into the affected area, stimulating the growth of new blood vessels. This process can reduce pain and improve ulcer healing rates, offering a promising alternative to surgical interventions.
Researchers at U-M have discovered that inflammatory cytokines are the primary cause of graft-versus-host disease, which can be prevented by neutralizing these proteins. The study's findings offer new hope for patients undergoing bone marrow transplants, with human clinical trials currently underway.
Researchers found that bone marrow stem cells naturally migrate to injured brain regions after a stroke to aid in tissue repair. These cells can form new neurons and blood vessels, potentially enhancing recovery from stroke-related damage.
Researchers have successfully treated five patients with severe chest pain with injections of their own bone marrow cells, showing increased blood flow in treated areas. The treatment appears safe and relatively inexpensive with no reported side effects.
Researchers found that bone marrow-derived cells contribute to tumor blood vessel formation and promote growth. Targeting specific VEGF receptors blocks tumor formation, offering potential new therapeutic approaches.
Researchers at University of Wisconsin-Madison successfully directed undifferentiated human embryonic stem cells to become primitive types of blood cells, which later develop into mature blood cells. This breakthrough technology holds promise for creating novel sources of blood cells for transfusion and transplant therapies.